Neurokeys is currently available to: - People with a Multiple Sclerosis (MS) diagnosis in the United States, prescribed by their doctor through a participating healthcare provider. - Participants in clinical studies in both the EU and the US, enrolled through a hospital, university, or research partner. You cannot download Neurokeys independently from the App Store or Google Play -- access is always through a healthcare provider or study team. We plan to expand to additional conditions and regions over time.
Who can use Neurokeys?
Written by Alex